News
1h
Zacks Investment Research on MSNOnto Innovation (ONTO) Falls More Steeply Than Broader Market: What Investors Need to KnowIn the latest close session, Onto Innovation (ONTO) was down 1.08% at $101.76. This change lagged the S&P 500's 0.33% loss on the day. Meanwhile, the Dow experienced a drop of 0.63%, and the ...
From time to time, investors like to look for fresh insights outside the world of markets. In the latest piece for his ...
Meta’s $100 million sign-up bonuses have underscored the value of cutting-edge tech talent. Indian businesses should also be ...
HSBC analyst Frank Lee just upgraded Advanced Micro Devices (AMD) from “Hold” to “Buy,” doubling its price target from $100 to $200 per share, implying a 44.5% upside from the stock’s closing price of ...
On July 8, 2025, trading in Chipotle call options exploded, with volume soaring to a level 145.8% above its daily average.
Traders have repeatedly shrugged off President Trump’s disruptive tariff wars and fiscal policy, pushing U.S. stock prices ...
Discover how Citadel Securities solidifies its dominance in market-making with a key acquisition from Morgan Stanley.
Glenmark Pharma shares hit upper circuit limit after signing a USD 2 billion deal with AbbVie for a cancer drug. Stock hits ...
After Glenmark’s landmark $2 billion licensing deal with US major AbbVie for its cancer drug, ISB 2001, the stock hit the 10% ...
The licensing deal is the largest one by any Indian pharma company, and the deal value is above expectations, said Nomura.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results